Thomas A. Ciulla

13.8k citations
220 papers · 9.6k indexed · 2 hit papers · h-index 54

Impact in

  • Ophthalmology top 0.02%
    • Retinal Diseases and Treatments
    • Glaucoma and retinal disorders
    • Retinal and Optic Conditions
    • Ocular Diseases and Behçet’s Syndrome
    • Ocular Infections and Treatments
    • Retinal Imaging and Analysis
    • Retinal and Macular Surgery

Papers in

    • Retinal Diseases and Treatments 144
    • Retinal and Optic Conditions 60
    • Glaucoma and retinal disorders 58
    • Ocular Diseases and Behçet’s Syndrome 34
    • Intraocular Surgery and Lenses 12
    • Retinal Imaging and Analysis 64
    • Retinal and Macular Surgery 15

Thomas A. Ciulla

211 papers receiving 9.2k citations

Hit Papers

Diabetic Retinopathy and Diabetic Macular Edema 2003 · 650 citations
6501997202620062016200400600

Peers

Thomas A. Ciulla
Comparison fields: 5 of 150
  • Ophthalmology 7.3k
  • Radiology, Nuclear Medicine and Imaging 4.3k
  • Biochemistry 406
  • Clinical Biochemistry 320
  • Neurology 353
Replace Jayakrishna Ambati with:
Jayakrishna Ambati United States
Luca Rossetti Italy
David S. Boyer United States
Alain M. Bron France
Stela Vujosevic Italy
Catherine Creuzot‐Garcher France
Stefano De Cillà Italy
Anita Agarwal United States
William B. Snyder United States
Davide Filippini Italy
Thomas A. Ciulla relative to Jayakrishna Ambati United States Jayakrishna Ambati's profile →
Citations per field
00.5×
Jayakrishna Ambati · 1×
Citations per year

Countries citing papers authored by Thomas A. Ciulla

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Ciulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Ciulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Ciulla more than expected).

Fields of papers citing papers by Thomas A. Ciulla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Ciulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Ciulla. The network helps show where Thomas A. Ciulla may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas A. Ciulla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas A. Ciulla Line = papers co-authored together Thomas A. Ciulla links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20244
4 20243
5 20243
6 202414
7 202213
8
Suprachoroidally delivered DNA nanoparticles produce human Myosin7A protein in RPE-choroid in rabbits
20211
9
Post hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis
20211
10 202158
11
Safety of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders
20213
12
Long-acting potential of suprachoroidally delivered BCX4161, a selective plasma kallikrein inhibitor, for diabetic macular edema
20215
13
Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension) in rabbits
20208
14
Suprachoroidal Delivery of Suspensions of Tyrosine Kinase Inhibitor, Complement Inhibitor, and Corticosteroid: Preclinical and Clinical Correlates
20204
15
Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits
20208
16
A theoretical study of vascular configurations of retinal capillary plexi based on OCTA data
20191
17 201746
18 20113
19
The Analytic and 12–Month Biological Variability of Retinal Oximetry Measurements in Patients With Non–Neovascular Age Related Macular Degeneration
20051
20
A New Spectrographic Digital Fundus Oxymeter: Effect of Hyperoxia on Retinal Oxygen Tension
20022

About Thomas A. Ciulla

Thomas A. Ciulla is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Microbiology, Molecular Biology and Biochemistry, having authored 220 papers that have together received 9.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (144 papers), Retinal Imaging and Analysis (64 papers), Retinal and Optic Conditions (60 papers), Glaucoma and retinal disorders (58 papers), Retinal Development and Disorders (45 papers), Ocular Diseases and Behçet’s Syndrome (34 papers), Retinal and Macular Surgery (15 papers) and Intraocular Surgery and Lenses (12 papers). The work is most often cited by research in Ophthalmology (7.3k citations), Radiology, Nuclear Medicine and Imaging (4.3k citations), Biochemistry (406 citations), Clinical Biochemistry (320 citations) and Neurology (353 citations). Thomas A. Ciulla has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Alon Harris, Rehan M. Hussain, Ronald P. Danis, A. G. Amador, Bernard Zinman, David F. Williams, Michael B. Starr, Samuel Masket, Philip J. Rosenfeld and John S. Pollack. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Retina, Ophthalmology, American Journal of Ophthalmology and Expert Opinion on Biological Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026